Scandion Oncology: Initial reaction to CORIST phase II interim results
Research Note
2021-06-24
09:55
Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.
CB
Christian Binder
Disclosures and disclaimers